FrancophonIA/ELRC3.0 huggingface dataset:
English: In a separate trial, 224 patients with genotype 2 or 3 received PegIntron, 1.5 micrograms/kg subcutaneously, once weekly, in combination with ribavirin 800 mg -1,400 mg p.o. for 6 months (based on body weight, only three patients weighing > 105 kg, received the 1,400 mg dose) (Table 10).
Croatian: U drugom su ispitivanju 224 bolesnika s genotipom 2 ili 3 tijekom 6 mjeseci supkutano primala PegIntron u dozi od 1,5 mikrograma/kg jedanput na tjedan, u kombinaciji s ribavirinom peroralno u dozi od 800-1400 mg (na temelju tjelesne težine, samo su tri bolesnika koja su težila > 105 kg primila dozu od 1400 mg) (Tablica 10).
English: Table 3b Reduced PegIntron dose (0.25 g/kg) for the 0.5 g/kg monotherapy regimen in adults Body weight (kg)
Croatian: Tablica 3b Smanjenje doze lijeka PegIntron (0,25 µg/kg) u odraslih bolesnika koji primaju dozu od 0,5 µg/kg u monoterapiji Tjelesna težina (kg)
English: A large randomized trial compared the safety and efficacy of treatment for 48 weeks with two PegIntron/ribavirin regimens [PegIntron 1.5 µg/kg and 1 µg/kg subcutaneously once weekly both in combination with ribavirin 800 to 1,400 mg p.o. daily (in two divided doses)] and peginterferon alfa-2a 180 µg subcutaneously once weekly with ribavirin 1,000 to 1,200 mg p.o. daily (in two divided doses) in 3,070 treatment-naïve adults with chronic hepatitis C genotype 1.
Croatian: U velikom randomiziranom ispitivanju uspoređivala se sigurnost i djelotvornost 48-tjedne primjene dvaju režima liječenja kombinacijom lijeka PegIntron i ribavirina [PegIntron u supkutanoj dozi od 1,5 μg/kg ili 1 μg/kg jedanput na tjedan, u oba slučaja u kombinaciji s peroralnom dozom ribavirina od 800 do 1400 mg na dan (u dvije odijeljene doze)] i liječenja peginterferonom alfa-2a primijenjenim supkutano u dozi od 180 μg jedanput na tjedan sa 1000 do 1200 mg ribavirina peroralno na dan (u dvije odijeljene doze) u 3070 bolesnika s kroničnim hepatitisom C genotipa 1 koji prethodno nisu bili liječeni.
English: Use the reconstituted solution (solution you prepared by adding water for injection to the PegIntron powder) immediately or within 24 hours when stored in a refrigerator (2°C - 8°C).
Croatian: Pripremljenu otopinu (otopinu koju ste pripremili dodavanjem vode za injekcije u PegIntron prašak) primijenite odmah ili u roku od 24 sata, ako se čuva u hladnjaku (2°C-8°C).
English: PegIntron combination therapy (bitherapy or tritherapy) Bitherapy (PegIntron with ribavirin): applies to all adult and paediatric patients 3 years of age and older.
Croatian: Dvojna terapija (PegIntron s ribavirinom): vrijedi za sve odrasle i pedijatrijske bolesnike u dobi od 3 godine i starije.
English: Volume of PegIntron to administer (ml)
Croatian: Volumen lijeka PegIntron koji treba primijeniti (ml)
English: Please refer to the ribavirin SmPC for capsules or oral solution when PegIntron is to be used in combination with ribavirin.
Croatian: Molimo pročitajte Sažetak opisa svojstava lijeka za ribavirin kapsule ili oralnu otopinu ako će se PegIntron primjenjivati u kombinaciji s ribavirinom.
English: 9/l, and
Croatian: 9/l i
English: Use in adults - PegIntron alone
Croatian: Primjena u odraslih - PegIntron u kombiniranom liječenju
English: Use in adults - PegIntron in combination treatment This medicine, when given with ribavirin capsules, is usually given at a dose of 1.5 microgram per kilogram of body weight once a week.
Croatian: Kad se uzima u kombinaciji s kapsulama ribavirina, ovaj lijek se obično primjenjuje u dozi od 1,5 mikrograma po kilogramu tjelesne težine, jedanput na tjedan.
English: PegIntron 0.5 microgram/kg
Croatian: PegIntron 0,5 mikrograma/kg
English: Paediatric population (bitherapy only) - Dose to be administered Dosing for children 3 years of age and older and adolescent patients is determined by body surface area for PegIntron and by body weight for ribavirin.
Croatian: Za djecu u dobi od 3 i više godina i adolescente doziranje lijeka PegIntron se određuje prema tjelesnoj površini, a ribavirina prema tjelesnoj težini.
English: Second dose reduction to PegIntron 0.5 µg/kg
Croatian: Drugo smanjenje doze lijeka PegIntron na 0,5 μg/kg
English: Careful co-administration of theophylline with the product (PegIntron) is recommended.
Croatian: Preporučuje se oprez kod istodobne primjene teofilina s ovim lijekom (PegIntron).
English: a: p value based on Cochran-Mantel Haenszel Chi square test. b: p value based on chi-square test. c: subjects < 75 kg received 100 µg/week PegIntron and subjects ≥ 75 kg received 150 µg/week PegIntron.
Croatian: IU = milijun internacionalnih jedinica; a: p-vrijednost dobivena Cochran-Mantel Haenszelovim hi-kvadrat testom; b: p-vrijednost dobivena hi-kvadrat testom. c: ispitanici teški < 75 kg primali su 100 μg lijeka PegIntron na tjedan, a ispitanici teški ≥ 75 kg primali su 150 μg lijeka PegIntron na tjedan. d: doza ribavirina iznosila je 800 mg za bolesnike < 60 kg, 1000 mg za bolesnike 60-75 kg, te 1200 mg za bolesnike > 75 kg.
English: It is recommended that children and adolescent patients receiving PegIntron/ribavirin combination be discontinued from therapy if their week 12 HCV-RNA dropped < 2 log10 compared to pretreatment or if they have detectable HCV-RNA at treatment week 24.
Croatian: PegIntron/ribavirin ako im HCV-RNK u 12. tjednu padne za < 2 log10 u odnosu na vrijednost prije liječenja ili ako imaju mjerljivu HCV-RNK u 24. tjednu liječenja.
English: The following treatment-related adverse reactions were reported in adults in clinical trials or through post-marketing surveillance in patients treated with peginterferon alfa-2b, including PegIntron monotherapy or PegIntron/ribavirin.
Croatian: Sljedeće nuspojave povezane s liječenjem prijavljene su u odraslih osoba u kliničkim ispitivanjima ili tijekom praćenja nakon stavljanja lijeka u promet u bolesnika liječenih peginterferonom alfa-2b, uključujući PegIntron u monoterapiji ili kombinaciju PegIntron/ribavirin.
English: As monotherapy the PegIntron regimen is 0.5 or 1.0 µg/kg/week.
Croatian: U monoterapiji lijekom PegIntron primjenjuje se režim u dozi od 0,5 ili 1,0 μg/kg na tjedan.
English: PegIntron plus ribavirin
Croatian: PegIntron s ribavirinom
English: Table 6 Adverse reactions reported in adults in clinical trials or through post-marketing surveillance in patients treated with peginterferon alfa-2b, including PegIntron monotherapy or PegIntron + ribavirin
Croatian: Tablica 6 Nuspojave prijavljene u odraslih osoba u kliničkim ispitivanjima ili tijekom praćenja nakon stavljanja lijeka u promet u bolesnika liječenih peginterferonom alfa-2b, uključujući PegIntron u monoterapiji ili PegIntron + ribavirin
English: For adult patients who use 0.5 g/kg PegIntron monotherapy, dose reduction may be accomplished by reducing the prescribed volume by one-half as shown in Table 3b.
Croatian: U odraslih bolesnika koji primaju PegIntron u monoterapiji u dozi od 0,5 µg/kg smanjenje doze može se postići smanjenjem propisanog volumena za polovicu, kako je prikazano u Tablici 3b.
English: Table 3c Reduced PegIntron dose (0.5 g/kg) for the 1.0 g/kg monotherapy regimen in adults Body weight (kg)
Croatian: Tablica 3c Smanjenje doze lijeka PegIntron (0,5 µg/kg) u odraslih bolesnika koji primaju dozu od 1,0 µg/kg u monoterapiji Tjelesna težina (kg)
English: Table 4Effect of Peginterferon alfa-2b on Co-administered Medicines
Croatian: Tablica 4 Učinak peginterferona alfa-2b na lijekove u istodobnoj primjeni
English: PegIntron contains sucrose
Croatian: PegIntron sadrži saharozu
English: PegIntron 1.0 microgram/kg
Croatian: PegIntron 1,0 mikrograma/kg
English: PegIntron is supplied as: - 1 vial of powder for solution for injection and 1 ampoule of solvent for parenteral use; - 1 vial of powder for solution for injection, 1 ampoule of solvent for parenteral use, 1 injection syringe, 2 injection needles and 1 cleansing swab; - 4 vials of powder for solution for injection and 4 ampoules of solvent for parenteral use; - 4 vials of powder for solution for injection, 4 ampoules of solvent for parenteral use, 4 injection syringes, 8 injection needles and 4 cleansing swabs; - 6 vials of powder for solution for injection and 6 ampoules of solvent for parenteral use.
Croatian: PegIntron je dostupan u različitim veličinama pakiranja: - 1 bočica s praškom za otopinu za injekciju i 1 ampula s otapalom za injekciju; - 1 bočica s praškom za otopinu za injekciju, 1 ampula s otapalom za injekciju, 1 štrcaljka za injekciju, 2 igle za injekciju i 1 tupfer za čišćenje; - 4 bočice s praškom za otopinu za injekciju i 4 ampule s otapalom za injekciju; - 4 bočice s praškom za otopinu za injekciju, 4 ampule s otapalom za injekciju, 4 štrcaljke za injekciju, 8 igala za injekciju i 4 tupfera za čišćenje; - 6 bočica s praškom za otopinu za injekciju i 6 ampula s otapalom za injekciju; - 12 bočica s praškom za otopinu za injekciju, 12 ampula s otapalom za injekciju, 12 štrcaljki za injekciju, 24 igle za injekciju i 12 tupfera za čišćenje.
English: For adult patients who use 1.0 µg/kg PegIntron monotherapy, dose reduction may be accomplished by reducing the prescribed volume by one-half or by utilizing a lower dose strength as shown in Table 3c.
Croatian: U odraslih bolesnika koji primaju PegIntron u monoterapiji u dozi od 1,0 µg/kg smanjenje doze može se postići smanjenjem propisanog volumena za polovicu ili primjenom niže jačine doze, kako je prikazano u Tablici 3c.
English: The dose of PegIntron for monotherapy should be reduced in patients with moderate or severe renal impairment (see sections 4.2 and 4.4).
Croatian: Bolesnicima s umjerenim ili teškim oštećenjem funkcije bubrega treba smanjiti dozu lijeka PegIntron u monoterapiji (vidjeti dijelove 4.2 i 4.4).
English: Predictability of sustained virological response - Naïve patients: Virological response by week 12 is defined as at least 2-log viral load decrease or undetectable levels of HCV-RNA.
Croatian: Predvidljivost trajnog virološkog odgovora - bolesnici koji prethodno nisu bili liječeni: Virološki odgovor do 12. tjedna definira se kao smanjenje količine virusa za najmanje 2 log ili kao nemjerljiva HCV-RNK.
English: PegIntron is available in different pack sizes: - 1 vial of powder for solution for injection and 1 ampoule of solvent for injection; - 1 vial of powder for solution for injection, 1 ampoule of solvent for injection, 1 injection syringe,
Croatian: PegIntron je dostupan u pakiranjima koja sadrže: - 1 bočicu s praškom za otopinu za injekciju i 1 ampulu s otapalom za parenteralnu primjenu; - 1 bočicu s praškom za otopinu za injekciju, 1 ampulu s otapalom za parenteralnu primjenu,
English: The following instructions explain how to inject this medicine yourself.
Croatian: Sljedeće upute objašnjavaju kako ćete sami sebi dati injekciju lijeka PegIntron.
English: Please refer to the ribavirin and boceprevir Summary of Product Characteristics (SmPCs) when PegIntron is to be used in combination with these medicines.
Croatian: Molimo pročitajte Sažetak opisa svojstava lijeka za ribavirin i boceprevir ako će se PegIntron primjenjivati u kombinaciji s tim lijekovima.
English: Patients were randomized to receive either PegIntron (100 or 150 µg/week based on weight) plus ribavirin (800-1,200 mg/day based on weight) or interferon alfa-2b (3 MIU TIW) plus ribavirin (800-1,200 mg/day based on weight).
Croatian: Bolesnici su bili randomizirani tako da su primali PegIntron (100 ili 150 μg na tjedan ovisno o tjelesnoj težini) i ribavirin (800-1200 mg na dan ovisno o tjelesnoj težini) ili interferon alfa-2b (3 mil.
English: PegIntron/ribavirin retreatment of prior treatment failures In a non-comparative trial, 2,293 patients with moderate to severe fibrosis who failed previous treatment with combination alpha interferon/ribavirin were retreated with PegIntron, 1.5 micrograms/kg subcutaneously, once weekly, in combination with weight adjusted ribavirin.
Croatian: U nekomparativnom ispitivanju su 2293 bolesnika s umjerenom do teškom fibrozom, u kojih prethodno liječenje interferonom alfa u kombinaciji s ribavirinom nije bilo uspješno, ponovno liječena lijekom PegIntron u supkutanoj dozi od 1,5 mikrograma/kg jedanput na tjedan u kombinaciji s ribavirinom u dozi prilagođenoj tjelesnoj težini.
English: A small volume is lost during preparation of PegIntron for injection when the dose is measured and injected.
Croatian: Tijekom pripreme lijeka PegIntron za injekciju, pri mjerenju doze i davanju injekcije, izgubi se mali dio volumena.
English: The pharmacokinetics of PegIntron following a single subcutaneous dose of 1.0 microgram/kg were not affected by age.
Croatian: Dob nije utjecala na farmakokinetiku lijeka PegIntron nakon jedne supkutane doze od 1,0 mikrograma/kg.
English: Genotype 1* By week 4*** (n=950) HCV-RNA negative
Croatian: Genotip 1* Do 4. tjedna *** (n=950)
English: Your healthcare provider will instruct you how to self-inject this medicine.
Croatian: Vaš zdravstveni radnik će Vas uputiti kako da si sami date injekciju lijeka PegIntron.
English: When patients are administered PegIntron with medications metabolized by CYP1A2 or CYP2D6, the extent of the decrease in cytochrome P 450 activity is unlikely to have a clinical impact, except with medicines which have a narrow therapeutic margin (Table 5).
Croatian: Kada se PegIntron bolesnicima primjenjuje s lijekovima koji se metaboliziraju posredstvom CYP1A2 ili CYP2D6, razmjer smanjenja aktivnosti citokroma
English: Very common side effects (may affect more than 1 in 10 people): - breathing problems (including shortness of breath), - feeling depressed, - trouble sleeping, thinking or concentrating, dizziness, - severe stomach pain or cramps, - fever or chills beginning after a few weeks of treatment, - painful or inflamed muscles (sometimes severe),
Croatian: Vrlo česte nuspojave (mogu se javiti u više od 1 na 10 osoba): - tegobe s disanjem (uključujući nedostatak zraka), - depresivnost, - poteškoće sa spavanjem, razmišljanjem ili koncentracijom, omaglica, - jaka bol ili grčevi u trbuhu, - vrućica ili zimica koje se javljaju nakon nekoliko tjedana liječenja, - bolni ili upaljeni mišići (ponekad jako).
English: 1.0 g/kg
Croatian: 1 μg/kg
English: This medicine, when given alone, is usually given at a dose of 0.5 or 1.0 microgram per kilogram of body weight once a week, for 6 months to 1 year.
Croatian: Primjena u odraslih - liječenje samo lijekom PegIntron Kad se primjenjuje samostalno, ovaj lijek se obično daje u dozi od 0,5 ili 1,0 mikrograma po kilogramu tjelesne težine jedanput na tjedan, tijekom 6 mjeseci do godinu dana.
English: Table 2 Monotherapy dosing 0.5 µg/kg
Croatian: Tablica 2 Doziranje u monoterapiji 0,5 µg/kg
English: Please refer to the ribavirin SmPC when PegIntron is to be used in combination with ribavirin.
Croatian: Molimo pročitajte Sažetak opisa svojstava lijeka za ribavirin ako će se PegIntron primjenjivati u kombinaciji s ribavirinom.
English: In a clinical trial, approximately 1.2 % of patients treated with PegIntron or interferon alfa-2b in combination with ribavirin reported life-threatening psychiatric events during treatment.
Croatian: U jednom su kliničkom ispitivanju prijavljeni po život opasni psihijatrijski događaji u približno 1,2% bolesnika liječenih lijekom PegIntron ili interferonom alfa-2b u kombinaciji s ribavirinom.
English: No pharmacokinetic interactions were noted between PegIntron and ribavirin in a multiple-dose pharmacokinetic study.
Croatian: U ispitivanju farmakokinetike višekratnih doza nisu zabilježene farmakokinetičke interakcije između lijeka PegIntron i ribavirina.
English: PegIntron is available in different pack sizes: - 1 pre-filled pen containing powder and solvent for solution for injection, 1 needle ("Push-On Needle"),
Croatian: PegIntron je dostupan u pakiranjima koja sadrže: - 1 napunjenu brizgalicu (CLEARCLICK) s praškom i otapalom za otopinu za injekciju 1 iglu (potisna igla )
English: Patients were randomized to receive either PegIntron (1.5 µg/kg/week) plus ribavirin (800 mg/day) or interferon alfa-2b (3 MIU TIW) plus ribavirin (800 mg/day) for 48 weeks with a follow-up period of 6 months.
Croatian: Bolesnici su bili randomizirani u skupine koje su primale PegIntron (1,5 μg/kg na tjedan) i ribavirin (800 mg na dan) ili interferon alfa-2b (3 mil.
English: Careful co-administration of thioridazine with the product (PegIntron) is recommended.
Croatian: Preporučuje se oprez kod istodobne primjene tioridazina s ovim lijekom (PegIntron).
English: Discontinuation of PegIntron should be considered in patients who develop new or worsening ophthalmological disorders.
Croatian: U bolesnika u kojih se razviju novi ili pogoršaju postojeći oftalmološki poremećaji treba razmotriti obustavu lijeka PegIntron.
English: Amount of PegIntron to administer (µg)
Croatian: Količina lijeka PegIntron koju treba primijeniti (µg)
English: Therefore, each pre-filled pen contains an excess amount of solvent and PegIntron powder to ensure delivery of the labelled dose in 0.5 ml of PegIntron, solution for injection.
Croatian: Zato svaka napunjena brizgalica sadrži nešto veću količinu otapala i PegIntron praška kako bi se osigurala primjena deklarirane doze u 0,5 ml PegIntron otopine za injekciju.
English: Class label for interferon products, see below Pulmonary arterial hypertension.
Croatian: Značajka skupine lijekova koji sadrže interferon, vidjeti niže
English: Pen label - PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen
Croatian: Naljepnica brizgalice - PegIntron 150 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
English: Injection site reaction
Croatian: Opći poremećaji i reakcije na mjestu primjene
English: Therefore, each vial contains an extra amount of solvent and PegIntron powder to ensure delivery of the labeled dose in 0.5 ml of PegIntron, solution for injection.
Croatian: Stoga svaka bočica sadrži dodatnu količinu otapala i PegIntron praška kako bi se osigurala primjena deklarirane doze u 0,5 ml PegIntron otopine za injekciju.
English: nd dose reduction of PegIntron is to 0.5 µg/kg/week.
Croatian: Ako je potrebno, drugo smanjenje doze lijeka PegIntron je na 0,5 μg/kg na tjedan.
English: Monotherapy with PegIntron and bitherapy with PegIntron and ribavirin Naïve patients
Croatian: Monoterapija lijekom PegIntron i dvojna terapija lijekom PegIntron i ribavirinom Bolesnici koji prethodno nisu bili liječeni
English: PegIntron 120 micrograms powder and solvent for solution for injection EU/1/00/131/016
Croatian: PegIntron 120 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/131/016
English: PegIntron 1.5 micrograms/kg
Croatian: PegIntron 1,5 mikrograma/kg
English: PegIntron 80 micrograms powder and solvent for solution for injection EU/1/00/131/006
Croatian: PegIntron 80 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/131/006
English: 2 injection needles and 1 cleansing swab; - 4 vials of powder for solution for injection and 4 ampoules of solvent for injection; - 4 vials of powder for solution for injection, 4 ampoules of solvent for injection, 4 injection syringes, 8 injection needles and 4 cleansing swabs; - 6 vials of powder for solution for injection and 6 ampoules of solvent for injection; - 12 vials of powder for solution for injection, 12 ampoules of solvent for injection, 12 injection syringes, 24 injection needles and 12 cleansing swabs.
Croatian: 4 štrcaljke za injekciju, 8 igala za injekciju i 4 tupfera za čišćenje; - 6 bočica s praškom za otopinu za injekciju i 6 ampula s otapalom za parenteralnu primjenu; - 12 bočica s praškom za otopinu za injekciju, 12 ampula s otapalom za parenteralnu primjenu,
English: PegIntron 120 micrograms - vial of powder
Croatian: PegIntron 120 mikrograma - bočica s praškom
English: Pen label - PegIntron 100 micrograms powder and solvent for solution for injection in pre-filled pen
Croatian: Naljepnica brizgalice - PegIntron 100 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
English: 2 cleansing swabs; - 4 pre-filled pens containing powder and solvent for solution for injection, 4 needles ("Push-On Needle"),
Croatian: 2 tupfera za čišćenje - 4 napunjene brizgalice (CLEARCLICK) s praškom i otapalom za otopinu za injekciju 4 igle (potisna igla)
English: PegIntron 150 micrograms powder and solvent for solution for injection EU/1/00/131/021
Croatian: PegIntron 150 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/131/021
English: PegIntron 80 micrograms - vial of powder
Croatian: PegIntron 80 mikrograma - bočica s praškom
English: PegIntron 150 micrograms - vial of powder
Croatian: PegIntron 150 mikrograma - bočica s praškom
English: - Combination of PegIntron with telbivudine.
Croatian: PegIntron u kombinaciji s ribavirinom.
English: Package inserts of theophylline should be referred to when co-administering with the product (PegIntron)
Croatian: Potrebno je pročitati uputu o lijeku za teofilin kada se primjenjuje istodobno s ovim lijekom (PegIntron).
English: PegIntron 50 micrograms powder and solvent for solution for injection EU/1/00/131/001
Croatian: PegIntron 50 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/131/001
English: PegIntron 100 micrograms powder and solvent for solution for injection EU/1/00/131/011
Croatian: PegIntron 100 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/131/011
English: Detailed instructions for subcutaneous administration are provided at the end of this leaflet (see section “How to self-inject PegIntron”).
Croatian: Detaljne upute za potkožnu primjenu se nalaze na kraju ove upute (vidjeti dio
English: PegIntron 50 micrograms - vial of powder
Croatian: PegIntron 50 mikrograma - bočica s praškom
English: PegIntron 80 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/035
Croatian: PegIntron 80 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/131/035
English: PegIntron 100 micrograms - vial of powder
Croatian: PegIntron 100 mikrograma - bočica s praškom
English: PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/047
Croatian: PegIntron 150 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/131/047
English: Dental and periodontal disorders, which may lead to loss of teeth, have been reported in patients receiving PegIntron and ribavirin combination therapy.
Croatian: U bolesnika koji su primali kombiniranu terapiju lijekom PegIntron i ribavirinom prijavljene su bolesti zuba i parodonta koje mogu dovesti do gubitka zuba.
English: Discard the PegIntron pre-filled pen (CLEARCLICK) with any solution that is left in it after you give yourself the injection.
Croatian: Nakon što si date injekciju, zbrinite PegIntron napunjenu brizgalicu (CLEARCLICK) s preostalom neupotrijebljenom otopinom.
English: Interferon alfa-2b (3 MIU) + ribavirin (1,000/1,200 mg)
Croatian: IU) + ribavirin (1000/1200 mg)
English: PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/043
Croatian: PegIntron 120 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/131/043
English: PegIntron 50 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/031
Croatian: PegIntron 50 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/131/031
English: PegIntron 80 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution.
Croatian: PegIntron 80 mikrograma prašak i otapalo za otopinu za injekciju Svaka bočica mora se rekonstituirati sa 0,7 ml vode za injekcije za primjenu najviše 0,5 ml otopine.